These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 15282765)

  • 1. Quantitation of drug metabolites in the absence of pure metabolite standards by high-performance liquid chromatography coupled with a chemiluminescence nitrogen detector and mass spectrometer.
    Deng Y; Wu JT; Zhang H; Olah TV
    Rapid Commun Mass Spectrom; 2004; 18(15):1681-5. PubMed ID: 15282765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of parent drug and its unstable metabolites by in situ coulometric oxidation and liquid chromatography-tandem mass spectrometry.
    Tong W; Chowdhury SK; Su AD; Alton KB
    Anal Chem; 2010 Dec; 82(24):10251-7. PubMed ID: 21105697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of drugs in plasma without primary reference standards by liquid chromatography-chemiluminescence nitrogen detection: application to tramadol metabolite ratios.
    Ojanperä S; Rasanen I; Sistonen J; Pelander A; Vuori E; Ojanperä I
    Ther Drug Monit; 2007 Aug; 29(4):423-8. PubMed ID: 17667796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-speed gradient parallel liquid chromatography/tandem mass spectrometry with fully automated sample preparation for bioanalysis: 30 seconds per sample from plasma.
    Deng Y; Wu JT; Lloyd TL; Chi CL; Olah TV; Unger SE
    Rapid Commun Mass Spectrom; 2002; 16(11):1116-23. PubMed ID: 11992516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-low flow nanospray for the normalization of conventional liquid chromatography/mass spectrometry through equimolar response: standard-free quantitative estimation of metabolite levels in drug discovery.
    Valaskovic GA; Utley L; Lee MS; Wu JT
    Rapid Commun Mass Spectrom; 2006; 20(7):1087-96. PubMed ID: 16506151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The practical application of implementing the equimolar response principle of chemiluminescent nitrogen detection in pharmaceutical analysis.
    Liang X; Patel H; Young J; Shah P; Raglione T
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):723-30. PubMed ID: 18400446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of a prostaglandin D2 antagonist and its acyl glucuronide metabolite in human plasma by high performance liquid chromatography with tandem mass spectrometric detection--a lack of MS/MS selectivity between a glucuronide conjugate and a phase I metabolite.
    Schwartz MS; Desai RB; Bi S; Miller AR; Matuszewski BK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 837(1-2):116-24. PubMed ID: 16716772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential bias and mitigations when using stable isotope labeled parent drug as internal standard for LC-MS/MS quantitation of metabolites.
    Jian W; Edom RW; Xu Y; Gallagher J; Weng N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3267-76. PubMed ID: 21056016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput quantification for a drug mixture in rat plasma-a comparison of Ultra Performance liquid chromatography/tandem mass spectrometry with high-performance liquid chromatography/tandem mass spectrometry.
    Yu K; Little D; Plumb R; Smith B
    Rapid Commun Mass Spectrom; 2006; 20(4):544-52. PubMed ID: 16419023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of high-resolution mass spectrometry to investigate a metabolite interference during liquid chromatography/tandem mass spectrometric quantification of a small molecule in toxicokinetic study samples.
    Furlong M; Bessire A; Song W; Huntington C; Groeber E
    Rapid Commun Mass Spectrom; 2010 Jul; 24(13):1902-10. PubMed ID: 20533320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography-tandem mass spectrometry with respect to criteria for compound identification.
    Maralikova B; Weinmann W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Nov; 811(1):21-30. PubMed ID: 15458717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-dimensional liquid chromatography/mass spectrometry set-up for structural elucidation of metabolites in complex biological matrices.
    Kiffe M; Graf D; Trunzer M
    Rapid Commun Mass Spectrom; 2007; 21(6):961-70. PubMed ID: 17299833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative estimation of circulating metabolites without synthetic standards by ultra-high-performance liquid chromatography/high resolution accurate mass spectrometry in combination with UV correction.
    Yang Y; Grubb MF; Luk CE; Humphreys WG; Josephs JL
    Rapid Commun Mass Spectrom; 2011 Nov; 25(21):3245-51. PubMed ID: 22006386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative NMR: addressing metabolites in safety testing (MIST) guidance without using radiolabeled compounds and chemically synthesized metabolite standards.
    Vishwanathan K; Babalola K; Wang J; Espina R; Yu L; Adedoyin A; Talaat R; Mutlib A; Scatina J
    Chem Res Toxicol; 2009 Feb; 22(2):311-22. PubMed ID: 19067650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-performance liquid chromatography coupled to linear ion trap mass spectrometry for the identification of drug metabolites in biological samples.
    Dear GJ; James AD; Sarda S
    Rapid Commun Mass Spectrom; 2006; 20(8):1351-60. PubMed ID: 16555373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of a drug candidate and its metabolite in rat plasma samples using ultrafast monolithic column high-performance liquid chromatography/tandem mass spectrometry.
    Hsieh Y; Wang G; Wang Y; Chackalamannil S; Brisson JM; Ng K; Korfmacher WA
    Rapid Commun Mass Spectrom; 2002; 16(10):944-50. PubMed ID: 11968126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing throughput and information content for in vitro drug metabolism experiments using ultra-performance liquid chromatography coupled to a quadrupole time-of-flight mass spectrometer.
    Castro-Perez J; Plumb R; Granger JH; Beattie I; Joncour K; Wright A
    Rapid Commun Mass Spectrom; 2005; 19(6):843-8. PubMed ID: 15723446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro metabolite identification using fast gradient high performance liquid chromatography combined with tandem mass spectrometry.
    Hop CE; Tiller PR; Romanyshyn L
    Rapid Commun Mass Spectrom; 2002; 16(3):212-9. PubMed ID: 11803543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method for rapid metabolite profiling of drug candidates in fresh hepatocytes using liquid chromatography coupled with a hybrid quadrupole linear ion trap.
    Gao H; Materne OL; Howe DL; Brummel CL
    Rapid Commun Mass Spectrom; 2007; 21(22):3683-93. PubMed ID: 17937450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of a nanosplitter interface into an LC-MS-RD system to facilitate drug metabolism studies.
    Andrews CL; Li F; Yang E; Yu CP; Vouros P
    J Mass Spectrom; 2006 Jan; 41(1):43-9. PubMed ID: 16317713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.